These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6862721)

  • 1. Combined effect of alpha-methyldopa and a new enzyme inducer, Zixoryn, on the hepatic mixed-function monooxygenase system in humans.
    Gachályi B; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):183-5. PubMed ID: 6862721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Trifluoromethyl-alpha-ethylbenzhydrol (RGH-3332). Liver enzyme induction and D-glucaric acid excretion.
    Váradi A
    Arzneimittelforschung; 1978; 28(4):678-9. PubMed ID: 581947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tolerance of flumecinol (Zixoryn, RGH-3332), its regime and dosage in healthy volunteers.
    Vezekenyi Z; Ferenci J; Radnai B; Horvath T; Past T; Nagy L; Jávor T
    Int J Clin Pharmacol Res; 1983; 3(2):77-88. PubMed ID: 6679516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3-trifluoromethyl-alpha-ethylbenzhydrol (RGH-3332), a new enzyme inducer on the central nervous system of rats. Part II.
    Pálosi E; Szeberényi S; Szporny L
    Arzneimittelforschung; 1978; 28(4):669-72. PubMed ID: 581945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 3-trifluoromethyl-alpha-ethylbenzhydrol (RGH-3332), a new enzyme inducer, on the microsomal drug metabolism. Part I.
    Szeberényi S; Pálosi E; Szporny L
    Arzneimittelforschung; 1978; 28(4):663-8. PubMed ID: 581944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a non-steroid anti-inflammatory agent on the drug metabolizing activity of the human liver.
    Gachályi B; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):353-4. PubMed ID: 6469424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of alpha methyldopa on the mixed oxygenase system of the liver in man].
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Orv Hetil; 1979 Apr; 120(15):897-8. PubMed ID: 372883
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enzyme inductive effect of zixoryn (3-trifluoromethyl-alpha-ethyl-benzhydrol) in neonatal jaundice].
    Korányi G; Boross G
    Monatsschr Kinderheilkd; 1985 Feb; 133(2):99-101. PubMed ID: 3982427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of zixoryn on pharmacokinetics of antipyrine in intact and sensitized guinea pigs].
    Khlopushina TG; Krinskaia AV; Kovalenko LP; Zherdev VP; Val'dman AV
    Biull Eksp Biol Med; 1991 Jul; 112(7):67-9. PubMed ID: 1793861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The function of the monooxygenase system of the liver in patients with psoriasis].
    Chichenina IV
    Vestn Dermatol Venerol; 1989; (8):32-5. PubMed ID: 2816028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m-Trifluoromethyl-alpha-ethylbenzhydrol: a new enzyme inducer.
    Gachályi B; Káldor A; Szeberényi S
    Eur J Clin Pharmacol; 1978 Jun; 13(4):299-302. PubMed ID: 668788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of a new compound (m-trifluormethyl-alpha-ethylbenxhydrol) on the mixed oxygenase function system of the liver].
    Gachályi B; Káldor A; Szeberényi S
    Orv Hetil; 1979 Jan; 120(1):16-8. PubMed ID: 760033
    [No Abstract]   [Full Text] [Related]  

  • 14. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enzyme inducer flumecinolum (Zixoryn) on aminophylline metabolism in rats.
    Szeitz A; Huszár E; Herjavecz I; Vértes K; Debreczeni LA
    Acta Physiol Hung; 1987; 70(2-3):317-21. PubMed ID: 3434310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic characteristics of zixoryn used in single and multiple doses].
    Kuz'min AI; Kukes VG; Chekhmakina OV
    Farmakol Toksikol; 1984; 47(3):108-14. PubMed ID: 6734803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of zixoryn on diuresis and renal transport of xenobiotics].
    Astaf'eva EP; Berkhin EB; Ul'ianov GP
    Biull Eksp Biol Med; 1987 Nov; 104(11):602-3. PubMed ID: 3676500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal environment and age influencing the activity of flumecinol, a synthetic enzyme inducer.
    Kulsár-Gergely J; Kulcsár A
    Arzneimittelforschung; 1981; 31(12):2101-3. PubMed ID: 7199306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable inhibition of human hepatic drug metabolizing enzymes by disulfiram.
    Freundt KJ
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):323-30. PubMed ID: 669879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The correction of the liver detoxifying function with phenobarbital and ziksorin before and after ischemia].
    Grek OR; Rybakova TA; Sharapov VI; Zakharova MV; Shkurupiĭ VA
    Eksp Klin Farmakol; 1993; 56(5):30-3. PubMed ID: 8312805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.